Home
Jazz Pharmaceuticals JAZZ paid Tarplin, Downs & Young $80K for lobbying in Q4 2024 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q4 2024
- Client
- Jazz Pharmaceuticals
- Reported
- 25/01/21
Up 0.0% from last quarter
What else happened in Jazz Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Jazz Pharmaceuticals's other lobbying reports
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$80K
$80K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$490K
$490K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/19
for Q2